Глаукома у собак: литература
Bingaman DP, Lindley DM, Glickman NW, et al: Intraocular gentamicin and glaucoma: A retrospective study of 60 dog and cat eyes (1985-1993). Vet Comp Ophthal 4:113,1994. A discussion of the indications, dosages, and complications of pharmacologic ciliary body ablation using gentamicin.
Brooks DE: Canine and feline glaucomas. In: Kirk RW, ed: Current Veterinary Therapy, 9th ed. Philadelphia: WB Saunders, 1986, pp 656-659. A discussion of the pathologic features and treatment of canine and feline glaucoma.
Cook C, Brinkmann M, Priehs D, et al: Diode laser transcleral cyclophoto-coagulation for glaucoma in dogs. 25th Sci Prog Am Coll Vet Ophthalmol 4:113, 1995. A description of the early results and outcome of diode laser CPC.
Derick RJ, Craig EL, Weber PA: Glaucoma therapy. In: Mauger TF, Craig EL, eds: Havener's Ocular Pharmacology, 6th ed. St. Louis: Mosby, 1994, pp 172-200. A discussion of the pharmacokinetics, uses, indications, and side effects of systemic and topical antiglaucoma therapy in humans.
Glover TL, Nasisse MP, Davidson MG: Effects of topically applied mitomycin-C on intraocular pressure, facility of outflow, and fibrosis after glaucoma filtration surgery in clinically normal dogs. Vet Comp Ophthal 56:936,1995. This study showed that mitomycin suppresses fibrosis around silicone filtering implants.
Kural E, Lindley D, Krohne S: Canine glaucoma-Part I. Compend ContinEduc 17:1017, 1995. A thorough discussion of the pathophysiology, clinical signs, and diagnosis of canine glaucoma.
Kural E, Lindley D, Krohne S: Canine glaucoma-Part II. Compend ContinEduc 17:1253, 1995. A thorough discussion of the goals of therapy for glaucoma and the medical and surgical therapy available for canine glaucoma.
Martin CL, Ward DA: Medical therapy for glaucoma. In: Kirk RW, Bonagura JD, eds: Kirk's Current Veterinary Therapy, 10th ed. Philadelphia: WB Saunders, 1989, pp 647-651. A discussion of the medical agents used in the treatment of canine and feline glaucoma.
Maus TL, Larsson LI, McLaren JW, et al: Comparison of dorzolamide and acetazolamide as suppressors of aqueous humor flow in humans. Arch Ophthalmol 115:45,1997. This study found that 2% dorzolamide was not as effective as systemically administered acetazolamide in reducing IOP in humans.
Miller PE: Glaucoma. In: Kirk RW, Bonagura JD, eds: Kirk's Current Veterinary Therapy, 12th ed. Philadelphia: WB Saunders, 1995, pp 1265-1272. A discussion of the pathogenesis, diagnosis, andtherapy for glaucoma.
Quinn RF, Parkinson K, Wilcock BP, et al: The effects of continuous wave Nd:YAG and semiconductor diode laser energy on the canine ciliary body: In vitro thermographic analysis. Vet Comp Ophthal 6:45, 1996. Comparison of the effects of the Nd:YAG and diode lasers on the canine ciliary body.
Scherlie JPH: Glaucoma. In: Kirk RW, Bonagura JD, eds: Kirk's Current Veterinary Therapy, 11th ed. Philadelphia: WB Saunders, 1992, pp 1125-1132. A discussion of aqueous humor dynamics, gfaucoma classification, and treatment.
Slater MR, Erb HN: Effects of risk factors and prophylactic treatment on primary glaucoma in the dog. J Am Vet Med Assoc 188:1028, 1986. An epidemiologic survey and discussion of the potential benefit of antiglaucoma prophylaxis in primary glaucoma of dogs.
Watson P, Stjernschantz J: Latanoprost Study Group: A sixmonth, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. Ophthalmology 103:126, 1996. This study found that latanoprost administered once daily reduced IOP as well as timolol administered twice daily in human patients with POAG.
